Argus Research Upgrades Biogen to Buy, Sets $280 Price Target
Argus Research upgraded Biogen to Buy from Hold and set a $280 price target. The target implies 12.2% upside from the Oct. 29 close of $249.65.
Argus Research upgraded Biogen to Buy from Hold and set a price target of $280.The price target implies an upside of 12.2% from the Oct 29 close of $249.65.Recent analyst actions on BiogenAcross the five most recent analyst notes published on Biogen over the past 30 days, price targets range from…